DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
O’Rourke DM, Nasrallah MP, Desai A. et al.
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.
Sci Transl Med 2017;
9: eaaa0984
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.